In contrast to blood components for transfusion, the demand for plasma derivatives is steadily increasing (around 6% per year) which also generates import flows from third countries into the EU.
Priešingai nei transfuzijai skirtų kraujo komponentų, plazmos darinių paklausa nuosekliai didėja (maždaug 6 proc.